HELIUM ION THERAPY
USPTO Trademark Record · Serial No. 75626174
Trademark details
It was initially claimed by Maurits W. Geerlings on 19990125.
That brand applies to the following goods and services:Cell directed therapy based on the use of alpha particle emitting isotopes, in particular, but not limited to Actinium-225 and Bismuth-213, labeled onto selected cell targeting agents, in particular, but not limited to peptides and mono clonal antibodies, or derivatives thereof This therapeutic concept refers to the treatment of cellular diseases, including cancer, auto-immune diseases (such as Rheumatoid Arthritis and Lupus Erythematosus),and AIDS.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the HELIUM ION THERAPY trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
